Long Term Clinical Implications in Chinese Patients With Aortic Intramural Hematoma

Long Term Follow-up and Clinical Implications in Chinese Patients With Aortic Intramural Hematoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03424785

Enrollment

270

Registered

2018-02-07

Start date

2008-06-03

Completion date

2017-05-14

Last updated

2018-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Intramural Hematoma

Keywords

Aortic intramural hematoma, Chinese patients, Clinical outcomes

Brief summary

The study evaluates outcomes of intramural hematomas after long-term follow up and establish predictive factors in Chinese population.

Detailed description

270 intramural hematoma patients with clinical and imaging follow up were retrospectively studied in present study. The primary endpoint was consisted of aortic disease-related death, aortic dissection, penetrating atherosclerotic aortic ulcer , thickening of aorta hematoma and aortic complications requiring surgical or endovascular treatment.

Interventions

OTHERdrug, stent, surgical treatment

drug, stent, surgical treatment

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to 87 Years

Healthy volunteers

Inclusion criteria

* Type A aortic hematoma * Type B aortic hematoma

Exclusion criteria

* Aortic without initial intimal flap formation.

Design outcomes

Primary

Measure	Time frame	Description
hematoma thickness and a baseline MAD	14years	Medication and short-term imaging are recommended for Chinese IMH patients with a hematoma thickness less than 10.45 mm and a baseline MAD less than 44.75 mm. Rigorous medical observation should also be performed during the acute phase of IMH.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026